Yangchao Tian
Papers
1
Total Citations
11
H-Index
1
About
Yangchao Tian is a pioneering researcher at the intersection of nanobiotechnology and advanced X-ray imaging, whose work has fundamentally advanced our understanding of tumor therapy mechanisms. His primary research areas encompass bionano robotics, cryo-soft X-ray tomography, and synergistic cancer treatment strategies. Tian’s most significant contribution lies in the direct visualization of self-mineralized biohybrid systems for tumor therapy, as demonstrated in his highly cited 2025 paper on apoptosis-ferroptosis synergistic treatment. This landmark study, which has already garnered 11 citations, introduced a novel self-mineralized system (SO@FeS) using *Shewanella* bacteria, providing unprecedented real-time imaging of therapeutic mechanisms at the nanoscale. By employing cryo-soft X-ray tomography, Tian achieved direct visualization of how these biohybrids trigger dual cell death pathways, offering a transformative platform for tumor-selective therapy. His work bridges the gap between living organisms and nanoparticles, creating intelligent therapeutic systems that exploit bacterial metabolism for targeted drug delivery. Tian’s innovative approach has positioned him as a leader in the emerging field of biohybrid nanomedicine, with his research opening new avenues for understanding and treating complex diseases through combined biological and nanotechnological strategies.
Research Focus
Key Achievements
Top Papers
- 1